drugset / Trial / NCT00236886

Prospective Pilot Study on Metabolism and Weight Changes in Topiramate-Treated Epilepsy Patients

NCT00236886

Non-randomizedSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to assess a possible predictor for weight loss seen in epilepsy patients treated with topiramate.

Timeline

Start
1998-05
Primary completion
Completion
2000-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Topiramate Small molecule 25 mg Oral
Subject Topiramate Small molecule 400 mg Oral
Subject Topiramate Small molecule 1000 mg Oral